Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVEAL anacetrapib cardiovascular outcomes trial (China cohort)
CTR20140129Phase 3Active
- Sponsor
- Merck & Co.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anacetrapib in atherosclerotic disease, hypercholesterolemia, combined dyslipidaemia, sponsored by Merck & Co.. Started Jul 2015; status: active.
02
Drugs
anacetrapib
03
Conditions
atherosclerotic diseasehypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on CTR20140129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140129.